Clinical Trial Update: International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013) [Phase 3]

View source ↗

Summary

International Phase III trial HIT-HGG-2013 update; no results or status publicly available yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma Who Grade Iii
• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma Histone 3 K27m Who Grade Iv
• Glioblastoma Who Grade Iv
• Gliomatosis Cerebri

Snippet

Sponsor: University of Göttingen | Conditions: Glioblastoma WHO Grade IV, Diffuse Midline Glioma Histone 3 K27M WHO Grade IV | Phase 3 | Status: UNKNOWN